Development and characterization of acellular allogeneic arterial matrices

Tissue Engineering - Part A

Volumn 18, Issue 5-6, 2012, Pages 471-483

  Wilshaw, Stacy Paul ^a   Rooney, Paul ^b   Berry, Helen ^c   Kearney, John N ^c   Homer Vanniasinkam, Shervanthi ^d   Fisher, John ^a   Ingham, Eileen ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c Tissue Regenix Group plc   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CYTOLOGY; GRAFTS; SODIUM; TENSILE TESTING; TISSUE;

ACELLULAR TISSUES; ARTERIAL ANEURYSMS; BIOMECHANICAL PROPERTIES; BURST PRESSURES; CRYO-PRESERVATION; CRYOPRESERVED; CYTOTOXIC; DECELLULARIZATION; DECELLULARIZED; FEMORAL ARTERY; FREEZE-THAW CYCLES; HAMSTER KIDNEYS; HISTOLOGICAL ANALYSIS; LOW CONCENTRATIONS; OCCLUSIVE DISEASE; PATENCY RATES; PERACETIC ACIDS; SODIUM DODECYL SULPHATE; STRUCTURAL PROTEINS; TENSILE TESTS; TRIS BUFFERS; ULTRA LOW TEMPERATURES; VASCULAR GRAFTS; VIABLE CELLS;

CELLS;

CRICETINAE;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CELL STRAIN 3T3; CHEMISTRY; CLINICAL TRIAL; FEMALE; FEMORAL ARTERY; HAMSTER; HUMAN; MALE; MATERIALS TESTING; METHODOLOGY; MOUSE; ORGAN TRANSPLANTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TRANSPLANTATION;

3T3 CELLS; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CRICETINAE; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MATERIALS TESTING; MICE; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84857855210     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0287     Document Type: Article

References (44)

1. Deutsch, M., Meinhart, J., Fischlein, T., Preiss, P., and Zilla, P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126, 847, 1999.
2. Teebken, O.E., and Haverich, A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 23, 475, 2002.
3. Van Det, R.J., Vriens, B.H., van der Palen, J., and Geelkerken, R.H. Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short-and long-term results of a multicentre randomised trial. Eur J Vasc Endovasc Surg 37, 457, 2009.
4. Bia Santana, D., Armentano, R., Zó calo, Y., Pérez Cámpos, H., Cabrera Fischer, E., Graf, S., et al. Functional properties of fresh and cryopreserved carotid and femoral arteries, and of venous and synthetic grafts: comparison with arteries from normotensive and hypertensive patients. Cell Tissue Bank 8, 43, 2007.
5. Dodd, P. What tissue bankers should know about the use of allograft blood vessels. Cell Tissue Bank 11, 3, 2010.
6. Sachs, S.M., Ricotta, J.J., Scott, D.E., and DeWeese, J.A. Endothelial integrity after venous cryopreservation. J Surg Res 32, 218, 1982.
7. Benedetto, B., Lipkowitz, G., Madden, R., Kurbanov, A., Hull, D., Miller, M., et al. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. J Vasc Surg 34, 139, 2001.
8. Zdolsek, J.M., Morrison, W.A., Dingle, A.M., Palmer, J.A., Penington, A.J., and Mitchell, G.M. An "off the shelf" vascular allograft supports angiogenic growth in three-dimensional tissue engineering. J Vasc Surg 53, 435, 2011.
9. Schmidt, C.E., and Baier, J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21, 2215, 2000.
10. Konig, G., McAllister, T., Dusserre, N., Garrido, S.A., Lyican, C., Marini, A., et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30, 1542, 2009.
11. Nieponice, A., Soletti, L., Guan, J., Deasy, B.M., Huard, J., Wagner, W.R., et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, musclederived stem cells and a rotational vacuum seeding technique. Biomaterials 29, 825, 2008.
12. Piterina, A.V., Cloonan, A.J., Meaney, C.L., Davis, L.M., Callanan, A., Walsh, M.T., et al. ECM-based materials in cardiovascular applications: inherent healing potential and augmentation of native regenerative processes. Int J Mol Sci 10, 4375, 2009.
13. Gong, Z., and Niklason, L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22, 1635, 2008.
14. Badylak, J.S., Freytes, D.O., and Gilbert, T.W. Extracellular matrix as a biological scaffold material: structure and function. Biomaterials 5, 1, 2009.
15. Gilbert, T.W., Sellaro, T.L., and Badylak, S.F. Decellularization of tissues and organs. Biomaterials 27, 3675, 2006.
16. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin'oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
17. Gui, L., Muto, A., Chan, S.A., Breuer, C.K., and Niklason, L.E. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng Part A 15, 2665, 2009.
18. Schaner, P.J., Martin, N.D., Tulenko, T.N., Shapiro, I.M., Tarola, N.A., Leichter, R.F., et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 40, 146, 2004.
19. Daniel, J., Abe, K., and McFetridge, P.S. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J 51, 252, 2005.
20. Chan, R.W. The human umbilical vein as a biologic scaffold for vocal fold reconstruction. Bioengineering Conference, Proceedings of the 2010 IEEE 36th Annual Northeast, 2010, pp. 1-2 (accession no. 11290043).
21. Booth, C., Korossis, S.A., Wilcox, H.E., Watterson, K.G., Kearney, J.N., Fisher, J., et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11, 457, 2002.
22. Lomas, R.J., Cruse-Sawyer, J.E., Simpson, C., Ingham, E., Bojar, R., and Kearney, J.N. Assessment of the biological properties of human split skin allografts disinfected with peracetic acid and preserved in glycerol. Burns 29, 515, 2003.
23. Wilshaw, S.P., Kearney, J.N., Fisher, J., and Ingham, E. Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng 12, 2117, 2006.
24. Edwards, C.A., and O'Brien, W.D., Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104, 161, 1980.
25. Harding, J.J., and Wesley, J.M. The purification and amino acid composition of human uterus collagens, rheumatoidarthritis-nodule collagen and ox tendon collagen. Biochem J 106, 749, 1968.
26. Bank, R.A., Krikken, M., Beekman, B., Stoop, R., Maroudas, A., Lafeber, F.P., et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 16, 233, 1997.
27. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173, 1986.
28. Fujisato, T., Tomihata, K., Tabata, Y., Iwamoto, Y., Burczak, K., and Ikada, Y. Cross-linking of amniotic membranes. J Biomater Sci Polym Ed 10, 1171, 1999.
29. Eyre, D.R., Paz, M.A., and Gallop, P.M. Cross-linking in collagen and elastin. Annu Rev Biochem 53, 717, 1984.
30. Courtman, D.W., Errett, B., and Wilson, G.J. The role of crosslinking in modification of the immune response elicited aginst xenogeneic vascular acellular matrices. J Biomed Mater Res 55, 576, 2001.
31. Dardik, H., Wengerter, K., Qin, F., Pangilinan, A., Silvestri, F., Wolodiger, F., et al. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J Vasc Surg 35, 64, 2002.
32. Dardik, H. The second decade of experience with the umbilical vein graft for lower-limb revascularization. Cardiovasc Surg 3, 265, 1995.
33. Yow, K.H., Ingram, J., Korossis, S.A., Ingham, E., and Homer-Vanniasinkam, S. Tissue engineering of vascular conduits. Br J Surg 93, 652, 2006.
34. Stapleton, T.W., Ingram, J., Katta, J., Knight, R., Korossis, S., Fisher, J., et al. Development and characterization of an acellular porcine medial meniscus for use in tissue engineering. Tissue Eng Part A 14, 505, 2008.
35. Knight, R.L., Wilcox, H.E., Korossis, S.A., Fisher, J., and Ingham, E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H222, 129, 2008.
36. Huang, Q., Dawson, R.A., Pegg, D.E., Kearney, J.N., and Macneil, S. Use of peracetic acid to sterilize human donor skin for production of acellular dermal matrices for clinical use. Wound Repair Regen 12, 276, 2004.
37. Koenneker, S., Teebken, O.E., Bonehie, M., Pflaum, M., Jockenhoevel, S., Haverich, A., et al. A biological alternative to alloplastic grafts in dialysis therapy: evaluation of an autologised bioartificial haemodialysis shunt vessel in a sheep model. Eur J Vasc Endovasc Surg 40, 810, 2010.
38. Wilshaw, S.P., Kearney, J., Fisher, J., and Ingham, E. Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells. Tissue Eng Part A 14, 463, 2008.
39. Badylak, S.F. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 13, 377, 2002.
40. Mirsadraee, S., Wilcox, H.E., Watterson, K.G., Kearney, J.N., Hunt, J., Fisher, J., et al. Biocompatibility of acellular human pericardium. J Surg Res 143, 407, 2007.
41. Mirsadraee, S., Wilcox, H.E., Korossis, S.A., Kearney, J.N., Watterson, K.G., Fisher, J., et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 12, 763, 2006.
42. da Costa, F.D., Santos, L.R., Collatusso, C., Matsuda, C.N., Lopes, S.A., Cauduro, S., et al. Thirteen years' experience with the Ross Operation. J Heart Valve Dis 18, 84, 2009.
43. Bonn, D. "Serious concerns" over CryoLife heart valves. Lancet Infect Dis 2, 587, 2002.
44. Lumelsky, A. Transplant tissue: Cryolife human soft tissue implants recalled. J Law Med Ethics 30, 474, 2002.